The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global bone and joint health ingredients market reached a value of US$ 3.19 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.63 Billion by 2027, exhibiting at a CAGR of 6.29% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Bone and joint health ingredients refer to the herbal and natural extracts and compounds that are rich in essential nutrients and added to food and beverages to promote bone growth. The ingredients are primarily obtained from plant and animal-based sources, including turmeric, Boswellia, tart cherries, eggshell membranes and chondroitin. They have a high content of amino acids, calcium, collagen, glucosamine, chondroitin, magnesium and vitamin K and D. They are added to soft gel, pill, powder and liquid-based pharmaceuticals, nutraceuticals and dietary supplements to improve the structural matrix of the bones and minimize the risks of fractures. They also aid in enhancing the strength and flexibility of the joints in the body to prevent arthritis and other temporary or chronic joint disorders.
The increasing prevalence of orthopedic disorders, such as rheumatoid arthritis, tennis elbow and ligament injuries, is one of the key factors driving the growth of the market. Moreover, rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. With the increasing health consciousness, there is a rising acceptance for dietary and nutritional supplements among the masses. Athletes and fitness enthusiasts are also widely adopting bone and joint health and sports supplements to prevent nutritional deficiencies, joint deterioration and subsequent injuries in the body. Additionally, various product innovations, such as the launch of natural and organically sourced bone and joint health ingredients that cater to the requirements of the vegan population, are contributing to the growth of the market. Other factors, including significant growth in the pharmaceutical industry, along with rising healthcare expenditure capacities of the masses, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone and joint health ingredients market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on form, type, distribution channel, application and end user.
Breakup by Form:
Breakup by Type:
Breakup by Distribution Channel:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Amway Corp. (Alticor Inc.), Bioiberica S.A.U, Glanbia PLC, Herbalife Nutrition Ltd., Innophos Holdings Inc., Kappa Bioscience, Koninklijke DSM NV, NOW Foods, NutriGold Inc., Rousselot Inc. (Darling Ingredients), Waitaki Bio and William Reed Group Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Form, Type, Distribution Channel, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Amway Corp. (Alticor Inc.), Bioiberica S.A.U, Glanbia PLC, Herbalife Nutrition Ltd., Innophos Holdings Inc., Kappa Bioscience, Koninklijke DSM NV, NOW Foods, NutriGold Inc., Rousselot Inc. (Darling Ingredients), Waitaki Bio and William Reed Group Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at